Skip to main content
29) { ?>
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Federal Judge Forces FDA to Release Pfizer COVID-19 Vaccine Data, Which Includes 9 Pages of Side Effects


The Food and Drug Administration (FDA) was recently forced by a federal judge to release vaccine safety data on Pfizer’s COVID-19 shot.

Pfizer and the FDA had hoped to delay the release of the data by 75 years before the judge’s ruling.

However, Federal Judge Mark Pittman ordered them to release 55,000 pages the data per month.

From what has been released, there are 9 whole pages dedicated to side effects of the vaccine.

To complicate matters worse for Pfizer, they have recently pushed advertising for a drug used to treat the very heart conditions often caused by their vaccine.


Rebel News has more on the judge’s order:

The US Food and Drug Administration (FDA) attempted to delay the release of Pfizer’s COVID-19 vaccine safety data for 75 years despite approving the injection after only 108 days of safety review on December 11th, 2020.

The FDA originally said that they were prepared to release 500 pages per month in a response to the Freedom of Information (FOI) request filed on behalf of Public Health and Medical Professionals for Transparency (PHMPT) requesting the safety data.

Instead, in early January 2022, Federal Judge Mark Pittman ordered them to release 55,000 pages per month. They released 12,000 pages by the end of January.

Pfizer wanted to wait 75 YEARS before releasing this data to the public.

Gee, I wonder why…

Pfizer may be in some trouble soon.

They are now pushing advertising for a drug called Eliquis, which is used to treat heart conditions…

Oddly enough, it happens to treat the very heart conditions often caused by the COVID-19 vaccine itself…

The Defender has more on the advertising for Pfizer’s latest ‘Blockbuster’ drug, which treats heart conditions associated with their COVID-19 vaccine:

Two major pharmaceutical companies chose February, the month of love — or hearts — to launch an advertising campaign urging people experiencing heart issues for the first time to visit their doctors.

Pfizer and Bristol Myers Squibb (BMS) this month revived the “No Time to Wait” ad campaign, spending $1.28 million on TV ads alone.

The campaign warns anyone experiencing palpitations and shortness of breath that they may be at increased risk of developing atrial fibrillation (AF), deep vein thrombosis (DVT), other types of blood clots and strokes — the same types of cardiovascular ailments found among people who have received COVID-19 vaccines.

The campaign urges viewers to seek early medical attention in order to reduce the risk of these serious complications.

“Early medical attention” could include prescription drugs — including Eliquis, developed and marketed by none other than Pfizer and BMS.

29) { ?>


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

29) { ?>

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!